Erratum: Addendum and Corrigendum to "Subclinical cardiovascular disease and utility of coronary artery calcium score" [IJC Heart Vasculat. 37 (2021) 100909]

Affiliations

Published Erratum

Cihan Durmuş Saydam. Int J Cardiol Heart Vasc. 2023.

. 2023 Apr 21:46:101208.

doi: 10.1016/j.ijcha.2023.101208. eCollection 2023 Jun.

Abstract

[This corrects the article DOI: 10.1016/j.ijcha.2021.100909.].

Subclinical cardiovascular disease and utility of coronary artery calcium score.
Saydam CD. Saydam CD. Int J Cardiol Heart Vasc. 2021 Nov 17;37:100909. doi: 10.1016/j.ijcha.2021.100909. eCollection 2021 Dec. Int J Cardiol Heart Vasc. 2021. PMID: 34825047 Free PMC article. Review.

1. Wu R., et al. Nonalcoholic Fatty Liver Disease and CoronaryArtery Calcification in a Northern Chinese Population: a Cross SectionalStudy. Scientific Reports. 2017 doi: 10.1038/s41598-017-09851-5. - DOI - PMC - PubMed
1. Lee S.B., et al. Association between non-alcoholic fatty liverdisease and subclinical coronary atherosclerosis: An observational co-hort study. Journal of Hepatology. 2018 doi: 10.1016/j.jhep.2017.12.012. - DOI - PubMed
1. Cho Y.K., et al. The impact of non-alcoholic fatty liver dis-ease and metabolic syndrome on the progression of coronary artery cal-cification. Scientific Reports. 2018 doi: 10.1038/s41598-018-30465-y. - DOI - PMC - PubMed
1. Gummesson A., et al. Non-alcoholic fatty liver disease is astrong predictor of coronary artery calcification in metabolicallyhealthy subjects: A cross-sectional, population-based study in middle-aged subjects. PloS ONE. 2018 doi: 10.1371/journal.pone.0202666. - DOI - PMC - PubMed
1. Kwak M.S., et al. Nonalcoholic fatty liver disease is associatedwith coronary artery calcium score in diabetes patients with higherHbA1c. Diabetology & Metabolic Syndrome. 2015 doi: 10.1186/s13098-015-0025-4. - DOI - PMC - PubMed